![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Impact of a 12-Week Oral Regimen of Elbasvir/Grazoprevir (EBR/GZR) On Health-Related Quality of Life (HRQOL) and Fatigue in Treatment-Naïve Patients With Chronic Hepatitis C Virus (HCV) Genotype (GT) 1, 4, or 6 Infection: Data From the C-CORAL Study
|
|
|
Reported by Jules Levin
APASL:Asian Pacific Association for the Study of the Liver
Shanghai, China
February 15-19, 2017
Wendy Cheng1; Abhasnee Sobhonslidsuk2; Thuy Thi Thu Pham3; Fu-Sheng Wang4; Youn-Jae Lee5; Chi -Jen Chu6; Jidong Jia7; Pauline Lindore8; Liwen Liang8; Barvara Evans8;Joy Ginanni8; Rohit Talwani8; Jean Marie Arduino8
1Royal Perth Hospital, Perth, Australia; 2Ramathibodi Hospital, Mahidol University, Bangkok, Thailand; 3Hoa Hao Medical Ltd Company, Hoa Hao Hospital, Ho Chi Minh, Vietnam; 4Beijing 302 Hospital, Beijing, China; 5Inje University Busan Paik Hospital, Busan, South Korea; 6Taipei Veterans General Hospital, Taipei City, Taiwan; 7Beijing Friendship Hospital, Capital Medical University, Beijing, China; 8Merck & Co., Inc., Kenilworth, NJ, USA
![0315171](../images/031517/031517-4/0315171.gif)
![0315172](../images/031517/031517-4/0315172.gif)
![0315173](../images/031517/031517-4/0315173.gif)
![0315174](../images/031517/031517-4/0315174.gif)
![0315175](../images/031517/031517-4/0315175.gif)
![0315176](../images/031517/031517-4/0315176.gif)
![0315177](../images/031517/031517-4/0315177.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|